Autosomal Recessive Polycystic Kidney Disease (ARPKD)
1 clinical trials · Condition
◉ Watch Autosomal Recessive Polycystic Kidney Disease (ARPKD)
| Record | Firm | Date |
|---|---|---|
| A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) (NCT04786574) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-07-01 |
Track Autosomal Recessive Polycystic Kidney Disease (ARPKD) automatically
Every clearance here is in the API, with alerts when new ones post.